An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging (Intuition)
Sponsor: Apple Inc.
Terminated
Study was terminated early as part of Biogen's ongoing research and development portfolio management efforts.
Other terminated trials from Apple Inc.
More terminations from Apple Inc.
Listed as NCT05058950, this observational or N/A phase trial focuses on Mild Cognitive Impairment and Normal Aging and remains terminated or withdrawn. Sponsored by Apple Inc., it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Oct 2023 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jul 2022 — Oct 2023 [monthly]
Recruiting
-
Nov 2021 — Jul 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting
First recorded
Sep 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Apple Inc.
- Biogen
For direct contact, visit the study record on ClinicalTrials.gov .